Accelerating delivery of radiopharmaceutical trials
Radiopharmaceutical trials are gaining traction across oncology and other therapeutic areas—but challenges remain in delivery, access, and scalability. In this expert-led webinar, leaders in clinical research, regulatory strategy, operational execution, and patient advocacy explore how to de-risk and accelerate these programs through integrated planning and patient-focused design.
Hear directly from experts who have helped sponsors navigate the complexities of radiopharmaceutical development—from aligning nuclear medicine and oncology teams to designing inclusive trials and enabling access beyond academic hubs. Also featured is an oncology patient who participated in a radiopharmaceutical clinical trial, and he shares his journey and perspective on what drives patient engagement.
Related Insights
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Playbook
Radiopharmaceuticals are transforming precision oncology
Mar 11, 2026
Webinar
Global trial expansion: Navigating Australia & LATAM's evolving clinical research landscape
Dec 2, 2025
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Related Insights
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Playbook
Radiopharmaceuticals are transforming precision oncology
Mar 11, 2026
Webinar
Global trial expansion: Navigating Australia & LATAM's evolving clinical research landscape
Dec 2, 2025
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024